BeneVir is developing a therapeutic platform that has the potential to cure cancer in patients with advanced tumors
Location: United States, Maryland, Rockville
Employees: 11-50
Total raised: $3M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | BioHealth ... | biohealthi... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.02.2016 | - | $3M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 02.05.2018 | Term Sheet — Wednesday, May 2 | 5 Qs WITH A DEALMAKER In February, Reddit co-founder Alexis Ohanian said he would step down from hi... | fortune.co... |
| 16.02.2016 | Oncolytic immunotherapy startup BeneVir gets $3M | The company, launched in 2011, gets its core technology from New York University. BeneVir claims its... | medcitynew... |
| 26.11.2014 | Building viruses that kill cancer cells: BeneVir gets $2M, w... | The money will go toward the first proof-of-concept clinical studies, expand the startup’s pipeline ... | medcitynew... |
| 19.11.2014 | BeneVir Biopharm Receives Series A Investment from Pansend | BeneVir Biopharm, Inc., a Rockville, MD-based biotechnology company developing a pipeline of cancer ... | finsmes.co... |
| - | Building viruses that kill cancer cells: BeneVir gets $2M, w... | Immunotherapy is at the forefront of cancer care; however, most cancers evolve the ability to dodge ... | medcitynew... |
| - | Oncolytic immunotherapy startup BeneVir gets $3M | Maryland cancer vaccine upstart BeneVir is taking a two-pronged approach to immuno-oncology – it’s d... | medcitynew... |